County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis.
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis.
复制标题
DOI:
10.1016/j.lana.2022.100191
复制
发表时间:
2022-05
期刊:
影响因子:
--
通讯作者:
Jodar L
中科院分区:
文献类型:
--
作者:
McLaughlin JM;Khan F;Pugh S;Swerdlow DL;Jodar L
On Dec 14, 2020, the United States initiated a nationwide COVID-19 vaccination campaign. Demonstrating clear population-level impact following vaccine introduction helps to further elucidate and quantify the public-health benefits of vaccination. Using a negative binomial regression model we evaluated the ecological association between county-level COVID-19 vaccine uptake and rates of COVID-19 cases and deaths in the United States from April 1, 2021 through October 31, 2021 controlling for a broad set of county-level environmental, sociodemographic, economic, and health-status-related characteristics. County-level data were obtained from several publicly available databases that were merged for analysis. After adjustment for county-level characteristics, US counties with ≥ 80% of their residents ≥ 12 years of age fully vaccinated against COVID-19 had 30% (95% CI: 25−35; P < .001) and 46% (38−52; P < .001) lower rates of COVID-19 cases and deaths, respectively, versus those with <50% coverage (reference group). A dose response was observed: counties with 70−79% uptake had 20% (95% CI: 16−24; P < .001) and 35% (29−40; P < .001) lower rates of cases and deaths, respectively; counties with 60−69% uptake had 8% (5−11; P < .001) and 20% (15−24; P < .001) lower rates; and counties with 50−59% uptake had 2% (0−4; P =.09) and 8% (4−12; P < .001) lower rates. Restricting the analysis to the period when the Delta variant was predominant (June 1, 2021 ‒ October 31, 2021) showed similar findings. Our results showed that US counties with higher proportions of persons ≥ 12 years of age fully vaccinated against COVID-19 had substantially lower rates of COVID-19 cases and deaths—a finding that showed dose response and persisted even in the period when Delta was predominant. Pfizer.
登录
查看更多内容
DOI:
10.1056/nejmoa2034577
发表时间:
2020-12-31
期刊:
The New England journal of medicine
影响因子:
--
作者:
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者:
C4591001 Clinical Trial Group
影响因子:
82.9
作者:
Chemaitelly, Hiam;Yassine, Hadi M.;Abu-Raddad, Laith J.
通讯作者:
Abu-Raddad, Laith J.
DOI:
10.1056/nejmoa2035389
发表时间:
2021-02-04
期刊:
The New England journal of medicine
影响因子:
--
作者:
Baden LR;El Sahly HM;Essink B;Kotloff K;Frey S;Novak R;Diemert D;Spector SA;Rouphael N;Creech CB;McGettigan J;Khetan S;Segall N;Solis J;Brosz A;Fierro C;Schwartz H;Neuzil K;Corey L;Gilbert P;Janes H;Follmann D;Marovich M;Mascola J;Polakowski L;Ledgerwood J;Graham BS;Bennett H;Pajon R;Knightly C;Leav B;Deng W;Zhou H;Han S;Ivarsson M;Miller J;Zaks T;COVE Study Group
通讯作者:
COVE Study Group
影响因子:
56.3
作者:
Badr, Hamada S.;Du, Hongru;Gardner, Lauren M.
通讯作者:
Gardner, Lauren M.
DOI:
10.15585/mmwr.mm7020e2externalicon
发表时间:
2021-05-21
影响因子:
33.9
作者:
Pilishvili, Tamara;Fleming-Dutra, Katherine E.;Schrag, Stephanie
通讯作者:
Schrag, Stephanie